Merit Medical Systems Profit Margin 2006-2021 | MMSI

Current and historical gross margin, operating margin and net profit margin for Merit Medical Systems (MMSI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Merit Medical Systems net profit margin as of June 30, 2021 is 2.74%.
Merit Medical Systems Annual Profit Margins
Merit Medical Systems Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.032B $0.964B
Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.229B 19.74
Align Technology (ALGN) United States $56.840B 81.93
West Pharmaceutical Services (WST) United States $33.188B 64.09
Straumann Holding AG (SAUHF) Switzerland $32.360B 0.00
McKesson (MCK) United States $32.134B 10.38
Laboratory Of America Holdings (LH) United States $28.528B 8.73
AmerisourceBergen (ABC) United States $25.655B 14.09
Cooper (COO) United States $21.526B 33.28
Cardinal Health (CAH) United States $14.917B 9.47
DENTSPLY SIRONA (XRAY) United States $13.382B 20.62
Henry Schein (HSIC) United States $10.822B 17.69
STAAR Surgical (STAA) United States $6.795B 238.95
CONMED (CNMD) United States $3.792B 42.49
Patterson (PDCO) United States $3.015B 15.34
SmileDirectClub (SDC) United States $2.600B 0.00
Atrion (ATRI) United States $1.332B 42.71
Antares Pharma (ATRS) United States $0.636B 34.00
Retractable Technologies (RVP) United States $0.400B 7.79
Invacare (IVC) United States $0.205B 0.00
Vapor (HCMC) United States $0.204B 0.00
Milestone Scientific (MLSS) United States $0.135B 0.00
Biolase (BIOL) United States $0.104B 0.00
Pro-Dex (PDEX) United States $0.096B 23.57
Lifevantage (LFVN) United States $0.095B 6.86